AAV1-gamma-sarcoglycan gene therapy

· Genethon

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AAV1-gamma-sarcoglycan gene therapy, covering 2011-04-29 to 2011-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C [Phase 1]